Bench-to-bedside review: Severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors
Open Access
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 7 (3) , 226-232
Abstract
Nucleoside reverse transcriptase inhibitors (NRTIs) are effective antiretroviral therapy for the treatment of HIV-infected patients. NRTIs can induce mitochondrial impairment that leads to a number of adverse events, including symptomatic lactic acidosis. In the present review, we describe the underlying mechanism of NRTI-induced toxicity and the main clinical features of this infrequent, but severe, emerging complication. We also summarise experimental data and clinical observations that support the use of L-carnitine supplementation to reverse NRTI-induced mitochondrial impairment.Keywords
This publication has 55 references indexed in Scilit:
- Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with l-carnitineCritical Care Medicine, 2003
- Lactic Acidosis Associated with Stavudine Administration: A Report of Five CasesClinical Infectious Diseases, 2000
- Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosisEuropean Journal of Anaesthesiology, 1999
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Direct Interaction of the Mitochondrial Membrane Protein Carnitine Palmitoyltransferase I with Bcl-2Biochemical and Biophysical Research Communications, 1997
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic FunctionBiochemical and Biophysical Research Communications, 1993
- DidanosineDrugs, 1992
- L-carnitine deficiency in AIDS patientsAIDS, 1992
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990